Quick blood test could spot ICU patients at highest risk of death

NCT ID NCT07184593

Not yet recruiting Knowledge-focused Sponsor: Erasme University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This observational study tests a new bedside device that measures nucleosome levels in the blood of critically ill ICU patients. Researchers want to see if these levels can predict which patients are likely to die within 30 days. The study will enroll 130 adults with conditions like sepsis, shock, severe trauma, or brain injury. It does not test any treatment, only a diagnostic tool.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could give doctors a fast, bedside tool to predict which ICU patients are at highest risk of dying within 30 days, helping guide care decisions.
What could go wrong: This is an early observational study with only 130 participants. The test may not prove accurate enough for routine use, and results may not apply to all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute pancreatitis brain injury cardiac arrest cardiogenic shock infectious disease with sepsis injury pancreatitis post-cardiac arrest syndrome Sepsis Shock, Cardiogenic toxic shock syndrome Wounds, Nonpenetrating

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE BRAIN INJURY CARDIAC ARREST (CA) CARDIOGENIC SHOCK PANCREATITIS SEPSIS SEPTIC SHOCK TRAUMA BLUNT

More trials for these conditions

Other studies related to the condition(s) this trial covers.